Yatsen Holding Limited is a Guangzhou-based beauty group listed on the New York Stock Exchange under the ticker YSG. Founded in 2016, the company has built and acquired a portfolio of color cosmetics and skincare brands, including Perfect Diary, Little Ondine, and Pink Bear on the makeup side, alongside Galénic, DR.WU (its mainland China business), and Eve Lom in skincare. Investors follow YSG closely because it represents a prominent China-focused beauty operator navigating a strategic transformation from mass-market color cosmetics toward higher-margin, science-led skincare, with skincare now its largest revenue source.
Over the last 30 days, YSG moved from a closing price of $2.64 to approximately $1.86, a decline of about 29.5%. The pullback was not a single-day event: shares drifted lower through much of October before extending losses more sharply in early November.
The recent slide is part of a broader multi-month downtrend. About three months ago, the stock was trading near $3.40; as of the latest reading it sits near $1.86, representing a decline of roughly 45% over the trailing quarter. This indicates sustained selling pressure rather than an isolated correction. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The 30-day decline reflects continued pressure following the company's second-quarter earnings report released in early September, which showed revenue growth decelerating to 5.1% year over year and a widening net loss of RMB 90.8 million. While that report predated the strict 30-day window, its implications for slowing growth and shrinking profitability continued to weigh on the shares into October and November.
Investor concerns center on the company's cost structure. Selling and marketing expenses rose to 70.7% of revenue in the second quarter, driven by brand-building investments and higher traffic-acquisition costs on the Douyin platform. At the same time, color cosmetics revenue contracted 35.8% year over year as the company rationalized its brand portfolio and SKU range, creating near-term uncertainty about the pace of the skincare-led turnaround.
The stock's quarterly decline of roughly 45% follows a period in which YSG traded near $3.40 in late July before steadily giving up those gains. The dominant catalyst was the September earnings report, which confirmed that top-line momentum had slowed and that losses had widened compared with the prior-year period. The deceleration was especially notable because the first quarter had shown stronger 22.5% revenue growth, highlighting how quickly growth moderated.
The broader narrative shaping the quarter was the company's ongoing pivot toward premium skincare. Skincare revenue rose 40.4% year over year and now accounts for the majority of revenue, but the transition has been accompanied by higher marketing spend and inventory provisions in the declining color cosmetics segment. Combined with a cautious Chinese consumer environment and a dilutive convertible note placement completed in stages earlier in the year, these factors reinforced a risk-off tone around the shares.
Looking ahead, investors will monitor whether skincare momentum can be sustained while color cosmetics stabilizes. The company's next quarterly earnings release will be a key checkpoint for revenue growth, gross margin, and the trajectory of net losses, particularly whether selling and marketing costs as a percentage of revenue begin to moderate. The second tranche of the previously announced convertible notes, expected to be issued upon satisfaction of closing conditions, could also affect the share count and investor perception of dilution. Broader factors to watch include China's consumer spending environment, competitive dynamics in the beauty market, and any further progress in the company's international expansion strategy. From what I see, this transition phase remains the central theme to track.
In my analysis of names like YSG, I often review how different AI-driven approaches are positioned. Tickeron's Trending AI Robots page provides a useful overview of automated trading strategies that monitor this and other tickers. It highlights top-performing bots across various timeframes and styles, which can offer additional context when evaluating market sentiment around a stock.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
YSG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 38 of 42 cases where YSG's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +9.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where YSG advanced for three days, in 226 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on YSG as a result. In 91 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for YSG turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 45 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where YSG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for YSG entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.079) is normal, around the industry mean (20.672). P/E Ratio (-1.023) is within average values for comparable stocks, (16.840). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.518). Dividend Yield (0.000) settles around the average of (0.033) among similar stocks. P/S Ratio (0.362) is also within normal values, averaging (1.902).
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. YSG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. YSG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry HouseholdPersonalCare